Comprehensive analysis for viral elements and interleukin-28B polymorphisms in response to pegylated interferon plus ribavirin therapy in hepatitis C virus 1B infection (Q42980276)

From Wikidata

Jump to navigation Jump to search

scientific article published on November 2012

Language	Label	Description	Also known as
English	Comprehensive analysis for viral elements and interleukin-28B polymorphisms in response to pegylated interferon plus ribavirin therapy in hepatitis C virus 1B infection	scientific article published on November 2012

Statements

scholarly article

1 reference

Europe PubMed Central

12 November 2017

Comprehensive analysis for viral elements and interleukin-28B polymorphisms in response to pegylated interferon plus ribavirin therapy in hepatitis C virus 1B infection (English)

1 reference

Europe PubMed Central

12 November 2017

1 reference

based on heuristic

inferred from title

Hepatitis C virus

1 reference

based on heuristic

inferred from title

pegylated interferon

1 reference

based on heuristic

inferred from title

author name string

Shinya Maekawa

1

1 reference

Europe PubMed Central

12 November 2017

Minoru Sakamoto

2

1 reference

Europe PubMed Central

12 November 2017

Mika Miura

3

1 reference

Europe PubMed Central

12 November 2017

Makoto Kadokura

4

1 reference

Europe PubMed Central

12 November 2017

Ryota Sueki

5

1 reference

Europe PubMed Central

12 November 2017

Kazuki Komase

6

1 reference

Europe PubMed Central

12 November 2017

Hiroko Shindo

7

1 reference

Europe PubMed Central

12 November 2017

Nobutoshi Komatsu

8

1 reference

Europe PubMed Central

12 November 2017

Kuniaki Shindo

9

1 reference

Europe PubMed Central

12 November 2017

Asuka Kanayama

10

1 reference

Europe PubMed Central

12 November 2017

Takako Ohmori

11

1 reference

Europe PubMed Central

12 November 2017

Fumitake Amemiya

12

1 reference

Europe PubMed Central

12 November 2017

Shinichi Takano

13

1 reference

Europe PubMed Central

12 November 2017

Tatsuya Yamaguchi

14

1 reference

Europe PubMed Central

12 November 2017

Yasuhiro Nakayama

15

1 reference

Europe PubMed Central

12 November 2017

Takatoshi Kitamura

16

1 reference

Europe PubMed Central

12 November 2017

Taisuke Inoue

17

1 reference

Europe PubMed Central

12 November 2017

Shunichi Okada

18

1 reference

Europe PubMed Central

12 November 2017

Nobuyuki Enomoto

19

1 reference

Europe PubMed Central

12 November 2017

language of work or name

0 references

publication date

1 November 2012

1 reference

Europe PubMed Central

12 November 2017

1 reference

Europe PubMed Central

12 November 2017

56

1 reference

Europe PubMed Central

12 November 2017

1611-1621

1 reference

Europe PubMed Central

12 November 2017

5

1 reference

Europe PubMed Central

12 November 2017

The global burden of hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

The role of triple therapy in HCV genotype 1-experienced patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Impact of asian race on response to combination therapy with peginterferon alfa-2a and ribavirin in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Analysis of sequence configurations of the ISDR, PKR-binding domain, and V3 region as predictors of response to induction interferon-alpha and ribavirin therapy in chronic hepatitis C infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Mutations in the protein kinase-binding domain of the NS5A protein in patients infected with hepatitis C virus type 1a are associated with treatment response

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Sequence variation in hepatitis C virus nonstructural protein 5A predicts clinical outcome of pegylated interferon/ribavirin combination therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Ribavirin resistance in hepatitis C virus replicon-containing cell lines conferred by changes in the cell line or mutations in the replicon RNA.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Mutations in the NS5B region of the hepatitis C virus genome correlate with clinical outcomes of interferon-alpha plus ribavirin combination therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 1b high viral load and non-virological response to interferon-ribavirin combination therapy.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Contribution of Genome-Wide HCV Genetic Differences to Outcome of Interferon-Based Therapy in Caucasian American and African American Patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Pretreatment Sequence Diversity Differences in the Full-Length Hepatitis C Virus Open Reading Frame Correlate with Early Response to Therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

HCV genetic elements determining the early response to peginterferon and ribavirin therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Time-related changes in full-length hepatitis C virus sequences and hepatitis activity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

HCV substitutions and IL28B polymorphisms on outcome of peg-interferon plus ribavirin combination therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

The lipid droplet is an important organelle for hepatitis C virus production

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Analysis of interferon signaling by infectious hepatitis C virus clones with substitutions of core amino acids 70 and 91

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Phosphorylation of hepatitis C virus NS5A nonstructural protein: a new paradigm for phosphorylation-dependent viral RNA replication?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Hepatitis C virus NS5A: tales of a promiscuous protein

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Replication of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Efficient initiation of HCV RNA replication in cell culture

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Introduction of NS5A mutations enables subgenomic HCV replicon derived from chimpanzee-infectious HC-J4 isolate to replicate efficiently in Huh-7 cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Site-specific mutation of the interferon sensitivity-determining region (ISDR) modulates hepatitis C virus replication

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Interaction of Hepatitis C Virus Nonstructural Protein 5A with Core Protein Is Critical for the Production of Infectious Virus Particles

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Regulation of Hepatitis C Virion Production via Phosphorylation of the NS5A Protein

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25826

21 January 2018

Identifiers

10.1002/HEP.25826

1 reference

Europe PubMed Central

12 November 2017

1 reference

Europe PubMed Central

12 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42980276&oldid=2126241354"